A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer

StatusUnknown
PhaseNot specified
Started

Record status This record was last updated September 20, 2024 (before its estimated August 30, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study description expanded, about 44 words
    • Site details revised
    v5
  3. Start date: Dec 15, 2023 to Dec 29, 2023v4
  4. Start date: Oct 15, 2023 to Dec 15, 2023v3
  5. Start date: Aug 15, 2023 to Oct 15, 2023
    • Study title expanded, about 2 words
    v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
Trial Details
NCT Number NCT05991193
Lead Sponsor Hunan Province Tumor Hospital
Conditions
(from sponsor)		 NSCLC
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov